Invivyd Reports Third Quarter 2023 Financial Results and Recent Business Highlights
WALTHAM, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq:IVVD), a clinical-stage biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced financial results for the quarter ended September 30, 2023, and recent business highlights.
Related news for (IVVD)
- Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
- 24/7 Market News Snapshot 06 October, 2025 – Invivyd, Inc. Common Stock (NASDAQ:IVVD)
- MoBot alert highlights: NASDAQ: RZLV, NASDAQ: IVVD, NYSE: OPAD, NASDAQ: SOGP, NASDAQ: FTHM (08/28/25 11:00 AM)
- From Spider Silk to Silk Roads: Microcaps Flex Real-World Momentum
- Power Hour Playbook: Biotech Breakouts, Energy Movers & Niche Innovators to Watch Into the Close